Transforming Organizational Paradigms for Inclusive and Diverse Clinical Trial Research
Electra D. Paskett, PhD
Faculty Presentations
Transforming Organizational Paradigms for Inclusive and Diverse Clinical Trial Research
Electra D. Paskett, PhD
1 - Title Slide
2 - Disclosures
3 - Overview
4 - Agenda
5 - Section 1
6 - Diversity
7 - Why Is it Important?
8 - Health Disparities
9 - Socio-Economic Status
10 - Racial/Ethnic Representation
11 - Diverse Populations
12 - Section 2
13 - Clinical Trials Framework
14 - Model for Analysis
15 - Frameworks
16 - Section 3
17 - Operationalizing
18 - Operationalizing Frameworks
19 - Optimal Implementation
20 - Multi-Level Strategies
21 - Operationalizing Diversity
22 - Protocol Considerations
23 - Enrollment Table
24 - Section 4
25 - Diversity in Trials
26 - Alliance
27 - Accrual Enhancement
28 - Alliance (cont'd)
29 - Enhancement Protocol
30 - Examples of Protocols
31 - Racial/Ethnic Minority
32 - Section 5
33 - Take Home Messages
34 - Conclusions
35 - Conclusions (Cont.)
36 - Questions
37 - Realizing Diversity
None Previous
1 / 37
Next »
Print This Page
Enlarge Figure
Title Slide
None Previous
1 / 37
Next »
Apply for Credit